Medpace Holdings Inc

6 nov 2026, 21:02 UTC

Charles River Laboratories is sharply higher following an analyst upgrade from Mizuho, moving in sympathy with Medpace Holdings, which is also trading higher.

5 nov 2026, 21:04 UTC

Medpace Holdings, Inc. is under investigation by Bronstein, Gewirtz & Grossman, LLC for potential corporate wrongdoing, raising governance concerns.

4 nov 2026, 21:07 UTC

Medpace Holdings, Inc. shares are declining amid a broader market downturn, as Charles River Laboratories reported a revenue decline and lowered fiscal guidance.

3 nov 2026, 21:02 UTC

Medpace Holdings, Inc. is trading higher, reflecting strong performance as it remains above its 20-day moving average, contrasting with the previous three sessions.

30 okt 2026, 20:03 UTC

Medpace Holdings, Inc. shares are declining, paralleling a drop in Charles River Laboratories, amid a sharp overall market decline during Friday's trading session.

29 okt 2026, 19:26 UTC

Medpace Holdings, Inc. is under investigation by Bronstein, Gewirtz & Grossman, LLC, regarding potential claims of corporate misconduct involving certain officers or directors.

28 okt 2026, 20:02 UTC

Medpace Holdings, Inc. is trading higher, reflecting positive momentum since Tuesday's close, alongside a notable increase in shares of Charles River Laboratories.

27 okt 2026, 19:36 UTC

Medpace Holdings, Inc. is under investigation by Bronstein, Gewirtz & Grossman, LLC for potential corporate wrongdoing claims involving the company and its officers or directors.

23 okt 2026, 20:08 UTC

Medpace Holdings Inc received multiple price target increases today, with Mizuho raising its target to $730 and Baird to $699, among others.

22 okt 2026, 20:03 UTC

Bronstein, Gewirtz & Grossman, LLC is investigating Medpace Holdings, Inc. for potential corporate misconduct involving the company and its executives.

21 okt 2026, 22:02 UTC

Medpace Holdings reported Q3 EPS of $4.84, exceeding estimates, and raised FY 2026 EPS guidance, but shares fell in after-hours trading amid revenue concerns.

20 okt 2026, 20:08 UTC

Citrini Research's bullish outlook on Charles River Laboratories has driven shares higher, while Medpace Holdings remains stable near the upper end of its trading range.

16 okt 2026, 20:07 UTC

Medpace Holdings Inc shares are declining, finishing significantly lower since Thursday's close, despite a slight recovery earlier in the session.

15 okt 2026, 20:07 UTC

Medpace Holdings Inc shares advanced during Thursday's session, supported by a maintained Buy rating on Thermo Fisher Scientific Inc and strong user commentary on performance.

14 okt 2026, 20:07 UTC

Medpace Holdings Inc shares are advancing, following an early surge that marked its highest cumulative return, despite some retracement during Wednesday's trading session.

12 okt 2026, 19:56 UTC

Medpace Holdings Inc is trading higher, having gained traction since Friday and currently positioned above its 20-day moving average.

9 okt 2026, 20:06 UTC

Medpace Holdings Inc is advancing, benefiting from broader market gains since Thursday, despite pulling back slightly from an earlier session peak.

8 okt 2026, 21:40 UTC

Medpace Holdings Inc is trading lower in after-market hours, continuing a decline since Thursday's close and indicating ongoing weakness below its 20-day moving average.

6 okt 2026, 20:00 UTC

Medpace Holdings Inc shares fell amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing involving the company and its officers.

5 okt 2026, 20:01 UTC

Charles River Laboratories is sharply higher after a positive earnings report, while Medpace Holdings is also advancing, despite earlier pulling back from a session high.

1 okt 2026, 20:02 UTC

Medpace Holdings Inc shares fell amid a broader market decline, reversing the recent trend of higher daily closes since Wednesday's close.

30 sep 2026, 19:35 UTC

UBS upgraded Medpace Holdings Inc to Neutral with a price target of $673, as shares trade higher amid strong historical performance despite recent insider selling.

25 sep 2026, 20:07 UTC

Medpace Holdings Inc shares fell, reflecting a decline from Thursday's close, amid sympathy with Thermo Fisher Scientific Inc, which is also down.

24 sep 2026, 20:07 UTC

Medpace shares are modestly higher as President and CEO August J. Troendle sold 70.9k shares for about $44.43 million, following strong revenue growth.

23 sep 2026, 20:01 UTC

Medpace Holdings Inc shares fell sharply on Wednesday, aligning with a decline in Charles River Laboratories, despite remaining above its 20-day moving average.

22 sep 2026, 23:01 UTC

Medpace Holdings Inc is rising in after-market trading, continuing a trend above its 20-day moving average and closing higher for three consecutive sessions.

15 sep 2026, 20:01 UTC

Medpace Holdings Inc. is trading higher today despite negative broader market sentiment following a significant drop in the NY Empire State Manufacturing Index.

11 sep 2026, 20:08 UTC

Medpace Holdings Inc. is advancing during Friday's session, having reached a session high earlier, though it has since pulled back from that peak.

3 sep 2026, 20:07 UTC

Medpace Holdings shares are declining amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing involving the company and its officers.

2 sep 2026, 20:08 UTC

Medpace Holdings Inc. is rising amid broader gains in the Life Sciences Tools & Services sector, despite no specific company news driving the movement.